[
    [
        {
            "time": "2018-01-02",
            "original_text": "AbbVie Has Raised Its 2018 Earnings Guidance",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Earnings",
                    "Guidance",
                    "Raised"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "AbbVie Has Raised Its 2018 Earnings Guidance",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-03",
            "original_text": "Notable ETF Inflow Detected - MTUM, BA, ABBV, PYPL",
            "features": {
                "keywords": [
                    "ETF",
                    "Inflow",
                    "MTUM",
                    "BA",
                    "ABBV",
                    "PYPL"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "diversified"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Notable ETF Inflow Detected - MTUM, BA, ABBV, PYPL",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-01-04",
            "original_text": "Centene (CNC) Beats Q4 Earnings & Revenues, Ups '18 View",
            "features": {
                "keywords": [
                    "Centene",
                    "CNC",
                    "Beats",
                    "Q4",
                    "Earnings",
                    "Revenues",
                    "Ups",
                    "'18",
                    "View"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Centene (CNC) Beats Q4 Earnings & Revenues, Ups '18 View",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-05",
            "original_text": "Analysts’ Recommendations for AbbVie and Peers in January 2018",
            "features": {
                "keywords": [
                    "Analysts",
                    "Recommendations",
                    "AbbVie",
                    "Peers",
                    "January",
                    "2018"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Analysts’ Recommendations for AbbVie and Peers in January 2018",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-01-06",
            "original_text": "AbbVie's Imbruvica Gains 'Orphan Drug' Status",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Imbruvica",
                    "Orphan",
                    "Drug",
                    "Status"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "AbbVie's Imbruvica Gains 'Orphan Drug' Status",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-01-07",
            "original_text": "Centene (CNC) Beats Q4 Earnings & Revenues, Ups &apos;18 View",
            "features": {
                "keywords": [
                    "Centene",
                    "CNC",
                    "Beats",
                    "Q4",
                    "Earnings",
                    "Revenues",
                    "Ups",
                    "&apos;18",
                    "View"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Centene (CNC) Beats Q4 Earnings & Revenues, Ups &apos;18 View",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-08",
            "original_text": "Free Post Earnings Research Report: AbbVie’s Q4 FY17 Results Beat Market Estimates",
            "features": {
                "keywords": [
                    "Free",
                    "Post",
                    "Earnings",
                    "Research",
                    "Report",
                    "AbbVie",
                    "Q4",
                    "FY17",
                    "Results",
                    "Beat",
                    "Market",
                    "Estimates"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Free Post Earnings Research Report: AbbVie’s Q4 FY17 Results Beat Market Estimates",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]